elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26752729-18AA4160-8A2C-48AF-992D-30F59072A628
Q26752729-18AA4160-8A2C-48AF-992D-30F59072A628
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752729-18AA4160-8A2C-48AF-992D-30F59072A628
Current Management of NAFLD
P2860
Q26752729-18AA4160-8A2C-48AF-992D-30F59072A628
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26752729-18AA4160-8A2C-48AF-992D-30F59072A628
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
efb7c271b1e1e4d953681aa4c0901ff8ace3e58c
P2860
Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects.